Europe Medical Courier Market

The medical courier market size is expected to reach US$ 2,163.44 million in 2022 to US$ 3,207.44 million by 2030; it is estimated to record a CAGR of 5.0% during 2022-2030.

Rising Prevalence of Chronic Diseases

According to International Diabetes Federation, 2021, 1 in 11 adults have diabetes - 61 million. Europe has the highest number of children and adolescents with type 1 diabetes - 295,000. The top 5 countries for age-adjusted prevalence of people with diabetes (20-79 years) were Turkey, Spain, Andorra, Portugal, and Serbia. 

As per a white paper by Economist Impact, funded and initiated by AstraZeneca, Chronic kidney disease (CKD) affects about 1 in 10 adults across Europe. An estimated 100 million people in Europe are living with this long-term, progressive disease, and a further 300 million individuals will be at risk in 2023. 

Prostate cancer (PCa) is European men's most common non-cutaneous cancer. It is anticipated to exhibit declining mortality in the European Union (EU) due to various recent improvements in treatment. The incidence of PCa in Europe is high compared to other geographical areas such as Africa or Asia due to comparably high rates of prostate-specific antigen (PSA) screening, which were reported to be increasing in Eastern and Southern Europe. A biopsy helps in cancer detection in which a small amount of tissue from the area of the body where cancer may be present is taken, and that tissue is sent to a laboratory.

Thus, the increasing cases of chronic diseases such as diabetes, CKD, and cancer in the Europe is simultaneously propelling the demand for medical supplies and positively influencing the Europe medical courier market growth.

Growth Opportunities

Growing Strategic Initiatives

Several giants operating in the industry are taking strategic initiatives such as mergers & acquisitions, partnerships and collaborations, as well as unveiling new products to expand their foothold, support the end users in faster delivery of medical supplies, offer value-based care, and maintain a competitive edge in the market.

For instance, in April 2023, UPS Healthcare has opened its first dedicated healthcare logistics facility in Giessen, Germany. This new facility is capable of supporting storage of a range healthcare products at 2C to 8C, 15C to 25C and up to -20C degrees. Throughout 2023, UPS Healthcare will add over 2 million square feet of warehouse space, of which about half will be in Europe.

A consortium led by AGS Airports launched its next phase-Care and Equity - Healthcare Logistics UAS Scotland (CAELUS)-in partnership with NHS Scotland in September 2022. In August 2022 it secured US$ 12.56 million funding from the Future Flight Challenge at UK Research and Innovation. CAELUS brings together 16 partners, including Atkins, the University of Strathclyde, NATS, and NHS Scotland. Together they are work to deliver essential medicines, blood, and other medical supplies all over Scotland, including remote communities, through the first national drone network to transport. By securing US$ 1.86 million in January 2020, the CAELUS consortium designed drone landing stations for NHS sites across Scotland and made a virtual model (digital twin) of the planned delivery network, which connects hospitals, pathology laboratories, distribution centers, and GP surgeries across Scotland. NHS Scotland will bring its "Once for Scotland" approach to the project. Further, the second phase will involve live flight trials and remove remaining barriers to safely use drones at scale within Scotland's airspace.

The Europe medical courier market, based on product type, is segmented into lab specimens, medical supplies and equipment, blood and organs, medical notes, and others. The Europe medical courier market, in terms of destination, is fragmented into domestic and international. On the basis of service type, is bifurcated into standard services and rush and on-demand services. The Europe medical courier market, based on end user, is segmented into hospitals and clinics, diagnostic labs, pharmaceutical and biotechnology companies, blood and tissue banks, in-home support, and others.

Key players in the medical courier market secure growth through various strategies. In October 2022, Med Logistics Group Ltd partnered with Skyfarer and University Hospitals Coventry and Warwickshire (UHCW) NHS Trust to conduct a trial for Beyond Visual Line of Sight (BVLOS) drone in the UK. The drone is first-of-its-kind, and the trial was completed under secure CAA-approved airspace called "The Medical Logistics UK Corridor".

The National Health Service, National Health Services Blood and Transplant, Essex Partnership University NHS Foundation Trust, British Medical Association, and Department of Health and Social Care are a few key primary and secondary sources referred to while preparing the report on the medical courier market.